---
schema_version: "secwatch.filing_event.v1"
accession: "0000885725-26-000013"
form_type: "8-K"
ticker: "BSX"
cik: "0000885725"
company_name: "BOSTON SCIENTIFIC CORP"
filed_at: "2026-02-23T23:59:59+00:00"
generated_at: "2026-05-16T01:20:14.399529+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Boston Scientific boosts buyback by $4B to $5B; appoints two new directors

## Summary
- Board approved additional $4.0B stock repurchase authorization, total available now $5.0B.
- Board expanded from 10 to 12; appointed Catherine R. Smith (CFO of Starbucks) and Christophe P. Weber (CEO of Takeda).
- Smith and Weber will serve on audit and compensation committees; standard prorated compensation until 2026 annual meeting.
- Former directors John Sununu and Yoshiaki Fujimori will not stand for re-election at 2026 annual meeting.

## SEC filing metadata
- accession: 0000885725-26-000013
- form_type: 8-K
- ticker: BSX
- cik: 0000885725
- company_name: BOSTON SCIENTIFIC CORP
- filed_at: 2026-02-23T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885725/000088572526000013/0000885725-26-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885725/000088572526000013/bsx-20260218.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885725-26-000013
- JSON: https://secwatch.observer/filing/0000885725-26-000013.json
- Plain text: https://secwatch.observer/filing/0000885725-26-000013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.